|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
CA2257851C
(en)
*
|
1996-05-24 |
2011-11-15 |
Biogen, Inc. |
Modulators of tissue regeneration
|
|
US8709412B2
(en)
|
2001-06-29 |
2014-04-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulation of TIM receptor activity in combination with cytoreductive therapy
|
|
JP4689275B2
(ja)
*
|
2002-12-30 |
2011-05-25 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｋｉｍ−１アンタゴニストおよび免疫系を調節するための使用
|
|
EP1685159B1
(en)
*
|
2003-10-03 |
2012-08-01 |
Brigham & Women's Hospital |
Tim-3 polypeptides
|
|
TW200539890A
(en)
*
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
KR101213894B1
(ko)
*
|
2005-03-02 |
2012-12-20 |
바이오겐 아이덱 엠에이 인코포레이티드 |
Ｔｈ2 매개성 병태를 치료하기 위한 ｋｉｍ-1 항체
|
|
AU2007259329A1
(en)
|
2006-05-12 |
2007-12-21 |
Farris, Darise |
Anthrax compositions and methods of use and production
|
|
WO2009049115A1
(en)
*
|
2007-10-11 |
2009-04-16 |
University Of Maryland |
Methods for the treatment of viral conditions
|
|
JP2011500730A
(ja)
|
2007-10-26 |
2011-01-06 |
ガバニング カウンセル オブ ザ ユニバーシティ オブ トロント |
Ｔｉｍ−３を用いた治療および診断方法
|
|
WO2009064290A1
(en)
*
|
2007-11-13 |
2009-05-22 |
Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services |
Structure of tim family members
|
|
EP2252319A2
(en)
*
|
2008-01-29 |
2010-11-24 |
The Brigham and Women's Hospital, Inc. |
Methods for modulating a population of myeloid-derived suppressor cells and uses thereof
|
|
WO2010053610A2
(en)
*
|
2008-07-30 |
2010-05-14 |
Emergent Biosolutions, Inc. |
Stable anthrax vaccine formulations
|
|
ES2571235T3
(es)
*
|
2009-04-10 |
2016-05-24 |
Kyowa Hakko Kirin Co Ltd |
Procedimiento para el tratamiento de un tumor sanguíneo que utiliza el anticuerpo anti-TIM-3
|
|
KR101846590B1
(ko)
|
2010-06-11 |
2018-04-09 |
교와 핫꼬 기린 가부시키가이샤 |
항 ｔｉｍ-3 항체
|
|
US9623117B2
(en)
*
|
2011-04-04 |
2017-04-18 |
Wisconsin Alumni Research Foundation |
Method for selective targeting and entry of bacterial toxins to cells
|
|
US10179106B2
(en)
*
|
2011-05-12 |
2019-01-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomes comprising polymer-conjugated lipids and related uses
|
|
WO2014093627A2
(en)
*
|
2012-12-13 |
2014-06-19 |
Children's Medical Center Corporation |
Compositions and methods for inhibiting viral entry
|
|
WO2015048312A1
(en)
|
2013-09-26 |
2015-04-02 |
Costim Pharmaceuticals Inc. |
Methods for treating hematologic cancers
|
|
US10357559B2
(en)
|
2013-12-27 |
2019-07-23 |
Emergent Product Development Gaithersburg Inc. |
Temperature stable vaccine formulations
|
|
JOP20200094A1
(ar)
|
2014-01-24 |
2017-06-16 |
Dana Farber Cancer Inst Inc |
جزيئات جسم مضاد لـ pd-1 واستخداماتها
|
|
CN104072615B
(zh)
|
2014-01-26 |
2016-08-24 |
中国人民解放军军事医学科学院基础医学研究所 |
一种能阻断Tim-3信号通路的人Tim-3融合蛋白
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
ES2851451T3
(es)
*
|
2014-05-13 |
2021-09-07 |
Bavarian Nordic As |
Terapia de combinación para tratar cáncer con un poxvirus que expresa un antígeno de tumor y un anticuerpo monoclonal contra TIM-3
|
|
WO2016021599A1
(ja)
|
2014-08-04 |
2016-02-11 |
日東電工株式会社 |
液性免疫誘導促進用組成物及びワクチン医薬組成物
|
|
EP3191126B1
(en)
|
2014-09-13 |
2020-05-13 |
Novartis AG |
Combination therapies of alk inhibitors
|
|
KR20170106453A
(ko)
*
|
2015-01-29 |
2017-09-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
관문 억제제 및 백신 조합 및 면역요법을 위한 이들의 사용
|
|
SG11201810023QA
(en)
|
2016-05-27 |
2018-12-28 |
Agenus Inc |
Anti-tim-3 antibodies and methods of use thereof
|
|
AU2017297506A1
(en)
|
2016-07-14 |
2019-02-21 |
Bristol-Myers Squibb Company |
Antibodies against TIM3 and uses thereof
|
|
RU2019112860A
(ru)
|
2016-09-27 |
2020-10-30 |
Серо Терапьютикс, Инк. |
Молекулы химерных интернализационных рецепторов
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
RU2020114641A
(ru)
|
2017-09-26 |
2021-10-27 |
Серо Терапьютикс, Инк. |
Молекулы химерных интернализационных рецепторов и способы применения
|
|
US11197910B1
(en)
*
|
2020-08-19 |
2021-12-14 |
Vitruviae LLC |
Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases
|
|
WO2023201221A1
(en)
*
|
2022-04-11 |
2023-10-19 |
Duke University |
Recombinant tim-4 protein, chimeric antigen receptor (car) t cell delivery system and methods of making and using same
|